OnKure Therapeutics, Inc. OKUR Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by OnKure Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s change in lease liabilities?
- OnKure Therapeutics, Inc. (OKUR) reported change in lease liabilities of -$140K in Q1 2026.
- How has OnKure Therapeutics, Inc.'s change in lease liabilities changed year-over-year?
- OnKure Therapeutics, Inc.'s change in lease liabilities decreased by 7.7% year-over-year, from -$130K to -$140K.
- What is the long-term trend for OnKure Therapeutics, Inc.'s change in lease liabilities?
- Over 2 years (2022 to 2025), OnKure Therapeutics, Inc.'s change in lease liabilities has grown at a 10.7% compound annual growth rate (CAGR), from -$437K to -$536K.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.